|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-5-10
|
|
pubmed:abstractText |
Capecitabine is an established therapy for metastatic breast cancer. In Japan, a 4 weekly regimen is often used, but data for this schedule in the first-line setting are lacking.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1421-9794
|
|
pubmed:author |
pubmed-author:AbeChigusaC,
pubmed-author:AkagiKenzouK,
pubmed-author:Kinki Breast Cancer Study Group,
pubmed-author:MasudaNorikazuN,
pubmed-author:NakayamaTakahiroT,
pubmed-author:NishidaYukihiroY,
pubmed-author:NoguchiShinzaburoS,
pubmed-author:OginoNobuoN,
pubmed-author:SakamotoJunichiJ,
pubmed-author:TaguchiTetsuyaT,
pubmed-author:YoshidomeKatsuhideK,
pubmed-author:YoshikawaYukinobuY
|
|
pubmed:copyrightInfo |
(c) 2010 S. Karger AG, Basel.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
166-70
|
|
pubmed:meshHeading |
pubmed-meshheading:20407245-Adult,
pubmed-meshheading:20407245-Aged,
pubmed-meshheading:20407245-Antimetabolites, Antineoplastic,
pubmed-meshheading:20407245-Breast Neoplasms,
pubmed-meshheading:20407245-Chemotherapy, Adjuvant,
pubmed-meshheading:20407245-Deoxycytidine,
pubmed-meshheading:20407245-Disease-Free Survival,
pubmed-meshheading:20407245-Female,
pubmed-meshheading:20407245-Fluorouracil,
pubmed-meshheading:20407245-Foot Dermatoses,
pubmed-meshheading:20407245-Hand Dermatoses,
pubmed-meshheading:20407245-Humans,
pubmed-meshheading:20407245-Japan,
pubmed-meshheading:20407245-Middle Aged,
pubmed-meshheading:20407245-Neoplasm Metastasis,
pubmed-meshheading:20407245-Neutropenia,
pubmed-meshheading:20407245-Survival,
pubmed-meshheading:20407245-Syndrome,
pubmed-meshheading:20407245-Time Factors,
pubmed-meshheading:20407245-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Study of low-dose capecitabine monotherapy for metastatic breast cancer.
|
|
pubmed:affiliation |
Department of Breast and Endocrine Surgery, Graduate School of Medicine, Osaka University, Suita, Japan. ttaguchi @ onsurg.med.osaka-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|
